Listen "Show 96 - PharmaComms - Part 1"
Episode Synopsis
The first of two episodes recorded in partnership with PRWeek UK at their PharmaComms conference in London where we chatted with a number of speakers from the event.
1/ Rachel Royall, Communications Director UK Healthcare & Life Sciences, IBM - 'What does patient-centricity mean for communications?'
2/ Christian Marcoux, Senior Vice President, Global Communications, Ipsen - 'Corporate Relevance - why relevance is the new reputation'
3/ Avril Fudge, Communications and PR Lead EMENA, Accord Healthcare - 'Informing and equipping employees to become brand ambassadors'
4/ David Flynn, Head Of External Communications, Roche; Charlotte Davies, Head of Communications, Healthcare, Merck; Kristine Kelly, Head of Communications and Patient Advocacy, UK, Novartis - 'Innovation and regulation: how to master the balancing act of communications in Pharma'
1/ Rachel Royall, Communications Director UK Healthcare & Life Sciences, IBM - 'What does patient-centricity mean for communications?'
2/ Christian Marcoux, Senior Vice President, Global Communications, Ipsen - 'Corporate Relevance - why relevance is the new reputation'
3/ Avril Fudge, Communications and PR Lead EMENA, Accord Healthcare - 'Informing and equipping employees to become brand ambassadors'
4/ David Flynn, Head Of External Communications, Roche; Charlotte Davies, Head of Communications, Healthcare, Merck; Kristine Kelly, Head of Communications and Patient Advocacy, UK, Novartis - 'Innovation and regulation: how to master the balancing act of communications in Pharma'
More episodes of the podcast the c-suite podcast
Show 276 - 10 years of FinTech Connect: Agentic AI, stablecoins and digital ID - Part 3 of 3
12/12/2025
Show 275 - 10 years of FinTech Connect: From Open Banking to Crypto Innovation - Part 2 of 3
10/12/2025
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.